Fabienne Thomas (F Thomas)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Clinical chemistry and laboratory medicine

Clinical pharmacology and therapeutics

British journal of clinical pharmacology

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Gaspard Loison, Hélène Bouges Le Royer, Sabrina Marsili, Aurélie Brice, Julien Vintejoux, Malika Yakoubi, Hélène Sirgue, Etienne Chatelut, Marie-Christine Etienne-Grimaldi, Fabienne Thomas, null null
Impact of hemolysis on uracilemia in the context of dihydropyrimidine dehydrogenase deficiency testing. Clinical chemistry and laboratory medicine (2024)
Anna M Mc Laughlin, Thomas Helland, Fenja Klima, Stijn L W Koolen, Ron H N van Schaik, Ron H J Mathijssen, Patrick Neven, Jesse Joachim Swen, Henk-Jan Guchelaar, Florence Dalenc, Melanie White-Koning, Robin Michelet, Gerd Mikus, Werner Schroth, Thomas Mürdter, Hiltrud B Brauch, Matthias Schwab, Håvard Søiland, Gunnar Mellgren, Fabienne Thomas, Charlotte Kloft, Daniel Louis Hertz, null null
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort. Clinical pharmacology and therapeutics (2024)
Fabienne Thomas, Manon Launay, Laure Raymond, Jérôme Guitton, Marie-Anne Loriot, Etienne Chatelut, Vincent Haufroid, Marie-Christine Etienne-Grimaldi
Reply to: "Is uracil enough for effective pre-emptive DPD testing?" Clinical chemistry and laboratory medicine (2024)
Gaspard Loison, Hélène Bouges Le Royer, Sabrina Marsili, Aurélie Brice, Julien Vintejoux, Malika Yakoubi, Hélène Sirgue, Etienne Chatelut, Marie-Christine Etienne-Grimaldi, Fabienne Thomas, null null
Impact of hemolysis on uracilemia in the context of dihydropyrimidine dehydrogenase deficiency testing. Clinical chemistry and laboratory medicine 62 (6) (2024)
Gaspard Loison, Hélène Bouges Le Royer, Sabrina Marsili, Aurélie Brice, Julien Vintejoux, Malika Yakoubi, Hélène Sirgue, Etienne Chatelut, Marie-Christine Etienne-Grimaldi, Fabienne Thomas, null null
Impact of hemolysis on uracilemia in the context of dihydropyrimidine dehydrogenase deficiency testing. Clinical chemistry and laboratory medicine 62 (6) (2024)
Gaspard Loison, Hélène Bouges Le Royer, Sabrina Marsili, Aurélie Brice, Julien Vintejoux, Malika Yakoubi, Hélène Sirgue, Etienne Chatelut, Marie-Christine Etienne-Grimaldi, Fabienne Thomas, null null
Impact of hemolysis on uracilemia in the context of dihydropyrimidine dehydrogenase deficiency testing. Clinical chemistry and laboratory medicine 62 (6) (2024)
Anna M Mc Laughlin, Thomas Helland, Fenja Klima, Stijn L W Koolen, Ron H N van Schaik, Ron H J Mathijssen, Patrick Neven, Jesse Joachim Swen, Henk-Jan Guchelaar, Florence Dalenc, Melanie White-Koning, Robin Michelet, Gerd Mikus, Werner Schroth, Thomas Mürdter, Hiltrud B Brauch, Matthias Schwab, Håvard Søiland, Gunnar Mellgren, Fabienne Thomas, Charlotte Kloft, Daniel Louis Hertz, null null
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort. Clinical pharmacology and therapeutics 116 (3) (2024)
Manon Launay, Laure Raymond, Jérôme Guitton, Marie-Anne Loriot, Etienne Chatelut, Vincent Haufroid, Fabienne Thomas, Marie-Christine Etienne-Grimaldi
Can we identify patients carrying targeted deleterious DPYD variants with plasma uracil and dihydrouracil? A GPCO-RNPGx retrospective analysis. Clinical chemistry and laboratory medicine (2024)
Ayman Al Saati, Pierre Vande Perre, Julien Plenecassagnes, Julia Gilhodes, Nils Monselet, Bastien Cabarrou, Norbert Lignon, Thomas Filleron, Dominique Telly, Emilie Perello-Lestrade, Viviane Feillel, Anne Staub, Mathilde Martinez, Edith Chipoulet, Gaëlle Collet, Fabienne Thomas, Laurence Gladieff, Christine Toulas
Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients. International journal of molecular sciences 24 (18) (2023)
C Arrivé, X Fonrose, Fabienne Thomas, G Roth, E Jacquet, A Brice, C Chirica, D Farneti, Coralie Frenoux, F Stanke-Labesque, Elodie Gautier-Veyret
Discrepancies between Dihydropyrimidine dehydrogenase phenotyping and genotyping: what are the explanatory factors? British journal of clinical pharmacology (2023)
Maud Maillard, Cécile Arellano, Christelle Vachoux, Christine Chevreau, Nicolas J Cabaton, Frederic Pont, Nathalie Saint-Laurent, Thierry Lafont, Etienne Chatelut, Fabienne Thomas
Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induced Liver Injury. Metabolites 12 (9) (2022)
Maud Maillard, Manon Launay, Bernard Royer, Jérôme Guitton, Elodie Gautier-Veyret, Sophie Broutin, Camille Tron, Félicien Le Louedec, Joseph Ciccolini, Damien Richard, Hugo Alarcan, Vincent Haufroid, Naïma Tafzi, Antonin Schmitt, Marie-Christine Etienne-Grimaldi, Céline Narjoz, Fabienne Thomas, null null
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency. British journal of clinical pharmacology (2022)
Fabienne Thomas, Manon Launay, Jérôme Guitton, Marie-Anne Loriot, Jean-Christophe Boyer, Vincent Haufroid, Marie-Christine Etienne-Grimaldi, Bernard Royer, null null
Plasma Uracil as a DPD Phenotyping Test: Pre-Analytical Handling Matters! Clinical pharmacology and therapeutics (2022)
Clémence Marin, Nihel Khoudour, Aurélien Millet, Dorothée Lebert, Pauline Bros, Fabienne Thomas, David Ternant, Bruno Lacarelle, Jérôme Guitton, Joseph Ciccolini, Benoit Blanchet
Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Maud Maillard, Audrey Eche-Gass, Mony Ung, Aurélie Brice, Sabrina Marsili, Marion Montastruc, Florent Puisset, Fabienne Thomas
Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines. Cancer chemotherapy and pharmacology 87 (4) (2021)
Félicien Le Louedec, Fanny Gallais, Fabienne Thomas, Melanie White-Koning, Ben Allal, Caroline Protin, Loïc Ysebaert, Étienne Chatelut, Florent Puisset
Limited Sampling Strategy for Determination of Ibrutinib Plasma Exposure: Joint Analyses with Metabolite Data. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Félicien Le Louedec, Florent Puisset, Fabienne Thomas, Étienne Chatelut, Melanie White-Koning
Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open-source R package mapbayr. CPT: pharmacometrics & systems pharmacology 10 (10) (2021)
Christine Chevreau, Christophe Massard, Aude Flechon, Rémy Delva, Gwenaëlle Gravis, Jean-Pierre Lotz, Jacques-Olivier Bay, Marine Gross-Goupil, Karim Fizazi, Loïc Mourey, Angelo Paci, Jérôme Guitton, Fabienne Thomas, Bénédicte Lelièvre, Joseph Ciccolini, Sotheara Moeung, Yohan Gallois, Pascale Olivier, Stéphane Culine, Thomas Filleron, Etienne Chatelut
Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors. Cancer medicine 10 (7) (2021)
Maud Maillard, Christine Chevreau, Félicien Le Louedec, Manon Cassou, Caroline Delmas, Laure Gourdain, Jean-Yves Blay, Didier Cupissol, Emmanuelle Bompas, Antoine Italiano, Nicolas Isambert, Corinne Delcambre-Lair, Nicolas Penel, François Bertucci, Cécile Guillemet, Julien Plenecassagnes, Stéphanie Foulon, Étienne Chatelut, Axel Le Cesne, Fabienne Thomas
Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma. Cancers 12 (12) (2020)
Félicien Le Louedec, Catherine Alix-Panabières, Thierry Lafont, Ben C Allal, Renaud Garrel, Laurence Digue, Joël Guigay, Didier Cupissol, Jean-Pierre Delord, Benjamin Lallemant, Marc Alfonsi, Karine Aubry, Martine Mazel, François Becher, Françoise Perriard, Etienne Chatelut, Fabienne Thomas
Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients. British journal of clinical pharmacology 85 (6) (2019)
Fabienne Thomas, Gareth J Veal, Souleiman El Balkhi, Thierry Lafont, Nicolas Picard, Laurence Brugieres, Étienne Chatelut, Christophe Piguet
Therapeutic drug monitoring and dose adaptation of cisplatin in a newborn with hepatoblastoma: a case report. Cancer chemotherapy and pharmacology 82 (2) (2018)